ItamarTM Medical Reports Success in Clinical Study Validating WatchPATTM for Central Sleep Apnea Differentiation, Submits Application for FDA Clearance of New WatchPATTM Version

New version of WatchPAT distinguishes between different subtypes of Sleep Apnea, ensuring a suitable therapeutic solution for patients

CAESAREA, Israel, June 9, 2016 – Itamar Medical Ltd. (TASE.ITMR), which develops, manufactures, and markets non-invasive diagnostic medical devices for cardiology and sleep related breathing disorders, reported success in a comprehensive clinical study based on initial results reported this week, and an FDA submission for a new WatchPAT version.